Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux, Boehringer Ingelheim, Evotec Launch €40M AMR-Targeted Joint Venture

NEW YORK – BioMérieux, Boehringer Ingelheim, and Evotec announced on Wednesday the creation of a joint venture to develop and commercialize new antimicrobials and diagnostics. Called Aurobac Therapeutics, the JV aims to fight antimicrobial resistance and will be established with €40 million ($40.8 million) in funding.

The firms expect Aurobac Therapeutics to enable a precision medicine approach to bacterial pathogen identification and treatment, offering an improvement over empirical approaches using broad-spectrum antimicrobials.

Aurobac Therapeutics will be headquartered in Lyon, France, and Boehringer Ingelheim will invest €30 million to establish the company, while Evotec and BioMérieux will each invest €5 million, according to a statement.

"The grim prospect of a post-antibiotic era has many causes but only one solution: the development of new, targeted, and effective antimicrobial therapies," said Werner Lanthaler, CEO of Evotec. "We are confident that Aurobac will be able to generate much-needed progress to tackle the global challenge of AMR," he added.

Alexandre Mérieux, BioMérieux's chairman and CEO, noted that the firm's role in the JV will be to develop and commercialize diagnostic tests, including companion diagnostics, which can deliver rapid, reliable, and actionable results. "This participation in Aurobac is perfectly aligned with BioMérieux's full commitment to sustain antibiotic efficacy for future generations," Mérieux said.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.